Showing results (761-770 of 1,188) with videos related to

Sort By:
Pageof 119
Journal of Clinical Medicine|February 26, 2025
Influence of Baseline Kidney Function on Patient and Kidney Outcomes in Patients with COVID-19: A Multi-National Observational StudyHarin Rhee, Etienne Macedo, Gary Cutter, et al.
Acta Neurochirurgica|November 6, 2024
The impact of early surgery on mortality and functional recovery in older adults with traumatic intracranial lesions: a propensity score-based analysisAna M Castaño-Leon, Pedro A Gomez, Luis Jimenez-Roldan, et al.
American Journal of Hematology|August 25, 2015
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decadeTalha Badar, Hagop M Kantarjian, Graciela M Nogueras-Gonzalez, et al.
Cancer|July 28, 2016
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomesTapan M Kadia, Preetesh Jain, Farhad Ravandi, et al.
Leukemia|August 1, 2022
High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significanceHui Yang, Guillermo Garcia-Manero, Koji Sasaki, et al.
American Journal of Hematology|January 25, 2013
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control studyElias Jabbour, Michael S Mathisen, Guillermo Garcia-Manero, et al.
Frontiers in Molecular Neuroscience|March 16, 2026
Clinical and genetic determinants of glioblastoma survival: a retrospective studyJulia L Gutiérrez-Arroyo, Pia Gallego-Porcar, Elvira Carbonell-Martinez, et al.
American Journal of Hematology|September 28, 2016
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemiasBrittany Knick Ragon, Hagop Kantarjian, Elias Jabbour, et al.
Cancer|January 30, 2023
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
International Journal of Hematology|March 5, 2019
Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Susan O'Brien, et al.
Pageof 119